FDA announces Pharmakon Pharmaceuticals’ nationwide voluntary recall of purportedly sterile drug products
[5/6/2016] FDA is alerting health care professionals of a voluntary recall of all non-expired drug compounded products intended to be sterile and distributed nationwide by Pharmakon Pharmaceuticals, Inc., of Noblesville, Indiana, due to a lack of sterility assurance and other quality issues. These compounded products are used for a variety of indications and are packaged in bags, syringes and cad cassettes. All recalled products have a label that includes the Pharmakon Pharmaceuticals, Inc., name, address and expiration date. The products were distributed nationwide to hospitals from March 4, 2016, to April 15, 2016. Health care professionals should immediately check their medical supplies, quarantine any drug products marketed as sterile from Pharmakon, and not administer them to patients. Administration of a non-s...